$15.51 +0.30 (%) Ironwood Pharmaceuticals Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus | Jul. 11, 2016 | 04:31AM EST
  2. Benzinga's Top Initiations

    Benzinga | Jan. 8, 2016 | 09:37AM EST
  3. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga | Oct. 27, 2015 | 05:37AM EST
  4. Allergan Acquires Rights to Ironwood's CONSTELLA from Almirall 40+ Countries

    Benzinga | Oct. 27, 2015 | 03:15AM EST
  5. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus | Aug. 25, 2015 | 12:37PM EST
  6. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.

    Benzinga | Aug. 5, 2015 | 08:25AM EST
  7. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973

    Benzinga | Jul. 22, 2015 | 06:34AM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 8, 2015 | 07:12AM EST
  9. Sucampo Stock Rebounds As Drug Gets Fast-Track Review

    IBD | May. 8, 2015 | 10:11AM EST
  10. The World's Top 10 Financial Bloggers

    GuruFocus | Jan. 12, 2015 | 16:36PM EST
  11. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  12. Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scientific Meeting

    Benzinga | Oct. 20, 2014 | 07:09AM EST
  13. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 11:10AM EST
  14. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga | Sep. 4, 2014 | 10:31AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Sep. 4, 2014 | 07:57AM EST
  16. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 10:04AM EST
  17. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering of Common Stock

    Benzinga | Feb. 10, 2014 | 16:12PM EST
  18. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature Bank Shares Gain On Strong Earnings

    Benzinga | Jan. 21, 2014 | 12:58PM EST
  19. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga | Jan. 21, 2014 | 10:56AM EST
  20. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus | Oct. 27, 2013 | 15:50PM EST
  21. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga | Oct. 24, 2013 | 14:14PM EST
  22. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., Ironwood Pharmaceuticals Inc. ...

    GuruFocus | Oct. 22, 2013 | 10:04AM EST
  23. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 22, 2013 | 09:13AM EST
  24. Earnings Scheduled For January 15, 2013

    Benzinga | Jan. 14, 2013 | 19:06PM EST
  25. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga | Dec. 20, 2012 | 23:36PM EST
  26. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus | Nov. 11, 2012 | 14:31PM EST
  27. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys 50,000 Shares

    GuruFocus | Nov. 6, 2012 | 10:41AM EST
  28. Ironwood and AstraZeneca Announce Linaclotide Collaboration for China

    Benzinga | Oct. 23, 2012 | 02:13AM EST
  29. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga | Aug. 30, 2012 | 07:01AM EST
  30. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; Maintains Sell

    Benzinga | Aug. 20, 2012 | 03:51AM EST
  31. Biotechs With Upcoming PDUFA Dates

    Benzinga | Jul. 18, 2012 | 08:09AM EST
  32. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga | Mar. 5, 2012 | 02:39AM EST
  33. Bank of America: Zelnorm vs. linaclotide

    Benzinga | Mar. 5, 2012 | 01:46AM EST
  34. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

    Benzinga | Feb. 13, 2012 | 02:14AM EST
  35. From Earlier: Ironwood Pharmaceuticals Prices Public Offering of 5.25M Shares at $15.09

    Benzinga | Feb. 10, 2012 | 00:18AM EST
  36. Ironwood Pharmaceuticals Announces Proposed Public Offering of 5.25M Shares

    Benzinga | Feb. 8, 2012 | 09:57AM EST
  37. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement

    Benzinga | Jan. 4, 2012 | 10:01AM EST
  38. European Patent Office Upholds Synergy Pharmaceuticals' Grant of Claims to Plecanatide

    Benzinga | Jan. 3, 2012 | 23:52PM EST
Trading Center